Chinese COVID-19 Trial Approaching End

Chinese COVID-19 Trial Approaching End

A United Arab Emirates company, Group42 or G42, is nearing the end of phase 3 clinical trials for a Chinese COVID-19 vaccine. They are hoping to start producing in the masses next year. This potential vaccine was a product of the partnership between G42, an Abu-Dhabi...
How AI is Changing the Face of Translation

How AI is Changing the Face of Translation

As the demand for quality affordable translations is ever increasing, the technology to deliver better and faster results is continually being improved upon. Companies are moving beyond traditional translation memory and terminology management systems to find new ways...